Definium Therapeutics, Inc. (DFTX) stock
DFTXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$32.08−0.92 (-2.79%)
Close on Nov 13, 2026Market cap $4.31BP/E –Yield –
Definium Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Definium Therapeutics's enterprise value was $3.58B on Nov 11, 2026, against $802.51M a year earlier. Over the last 5 years it ranged from -$71.93M to $4.56B, with a median of $274.95M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.58B | +317.1% |
| 2025 | Dec 31, 2025 | $859.32M | +189.4% |
| 2024 | Dec 31, 2024 | $296.90M | +588.6% |
| 2023 | Dec 29, 2023 | $43.12M | – |
| 2022 | Dec 30, 2022 | -$71.93M | -125.0% |
| 2021 | Dec 31, 2021 | $287.27M | – |
See a number that looks wrong?